Piramal Healthcare UK Ltd invests £2.0 million in Scotland

Mumbai: Piramal Healthcare UK Ltd has invested £2.0 million into Scotland to expand its manufacturing base of Antibody Drug Conjugates to global markets. This new investment into Scotland will yield additional revenue of £3-5 mn over 5 years to Piramal’s revenues the company said in a statement.

The new facility is expected to create up to 20 new high-skill job roles, backed by £200,000 Regional Selective Assistance funding.

“We have a thriving research and innovation led Life Sciences sector and Piramal is seeing the benefit of that as they manufacture products that are involved in the treatment of various types of cancer”, said Nicola Sturgeon First Minister, Scotland.

“Piramal Healthcare UK Ltd has been growing its operations in Grangemouth since 2005 and currently employs around 140 people in predominantly highly skilled positions. We aim to scale up this facility in the next 5 years to maintain its position as a global leader in the production of Antibody Drug Conjugates,” said Mark Wright, Piramal Healthcare Site Lead.